These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy. Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599 [TBL] [Abstract][Full Text] [Related]
4. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography. Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555 [TBL] [Abstract][Full Text] [Related]
5. Imaging of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Stewart M; Elagizi A; Gilliland YE Curr Opin Cardiol; 2023 Sep; 38(5):405-414. PubMed ID: 37115813 [TBL] [Abstract][Full Text] [Related]
6. Management of left ventricular outflow obstruction due to hypertrophic cardiomyopathy. Role of multimodality echocardiographic techniques. Luckie M; Khattar RS Minerva Cardioangiol; 2011 Dec; 59(6):581-9. PubMed ID: 22134470 [TBL] [Abstract][Full Text] [Related]
7. The predictive value of epicardial adipose tissue volume assessed by cardiac magnetic resonance for atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. Zhou Y; Yu M; Cui J; Hu F; Yang Z; Yuan J; Qiao S Int J Cardiovasc Imaging; 2021 Apr; 37(4):1383-1393. PubMed ID: 33392874 [TBL] [Abstract][Full Text] [Related]
8. Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy. Bogachev-Prokophiev AV; Afanasyev AV; Zheleznev SI; Pivkin AN; Fomenko MS; Sharifulin RM; Karaskov AM J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1536-1542.e2. PubMed ID: 28947201 [TBL] [Abstract][Full Text] [Related]
10. A Practical Approach to Echocardiographic Imaging in Patients With Hypertrophic Cardiomyopathy. Mitchell CC; Frye C; Jankowski M; Symanski J; Lester SJ; Woo A; Gilliland Y; Dragulescu A; Abraham T; Desai M; Martinez MW; Nagueh SF; Phelan D J Am Soc Echocardiogr; 2023 Sep; 36(9):913-932. PubMed ID: 37160197 [TBL] [Abstract][Full Text] [Related]
11. Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy: Equivalent Detection by Magnetic Resonance Imaging and Contrast Echocardiography. Lee DZJ; Chan RH; Montazeri M; Hoss S; Adler A; Nguyen ET; Rakowski H J Am Soc Echocardiogr; 2021 Dec; 34(12):1262-1272. PubMed ID: 34375676 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy. Webb J; Villa A; Bekri I; Shome J; Teall T; Claridge S; Jackson T; Porter B; Ismail TF; Di Giovine G; Rinaldi CA; Carr-White G; Al-Fakih K; Razavi R; Chiribiri A Am J Cardiol; 2017 May; 119(9):1450-1455. PubMed ID: 28267963 [TBL] [Abstract][Full Text] [Related]
14. [Role of multimodality imaging in the clinical evaluation of hypertrophic cardiomyopathy]. Guido V; Campana M; Pino PG; Moreo A; De Chiara B; Bertella E; Khoury G; G Ital Cardiol (Rome); 2019 Dec; 20(12):746-761. PubMed ID: 31834298 [TBL] [Abstract][Full Text] [Related]
15. Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: Importance of multi-modality imaging. Kherada N; Vinardell JM; Mihos CG; Santana O Echocardiography; 2017 Sep; 34(9):1392-1395. PubMed ID: 28573739 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches. Habib M; Hoss S; Rakowski H Curr Cardiol Rep; 2019 Jun; 21(8):75. PubMed ID: 31243594 [TBL] [Abstract][Full Text] [Related]
17. Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY). Hourqueig M; Bouzille G; Mirabel M; Huttin O; Damy T; Labombarda F; Eicher JC; Charron P; Habib G; Réant P; Hagège A; Donal E; Clin Res Cardiol; 2022 Feb; 111(2):163-174. PubMed ID: 34043053 [TBL] [Abstract][Full Text] [Related]
18. Left atrial dysfunction as marker of poor outcome in patients with hypertrophic cardiomyopathy. Essayagh B; Resseguier N; Michel N; Casalta AC; Renard S; Donghi V; Carbone A; Piazzai C; Ambrosi P; Levy F; Martel H; Gérard H; Avierinos JF; N'Guyen K; Habib G Arch Cardiovasc Dis; 2021 Feb; 114(2):96-104. PubMed ID: 33039326 [TBL] [Abstract][Full Text] [Related]
19. Multimodality Imaging Demonstrating an Apical Variant Hypertrophic Cardiomyopathy in an Uncommon Pentad. Fath AR; Jokerst CE; Aglan A; Mihyawi N; Mookadam F J Investig Med High Impact Case Rep; 2020; 8():2324709620934324. PubMed ID: 32551950 [TBL] [Abstract][Full Text] [Related]
20. The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy. Mandeş L; Roşca M; Ciupercă D; Popescu BA J Echocardiogr; 2020 Sep; 18(3):137-148. PubMed ID: 32301048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]